We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.6%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$610B
AUM Growth
-$181B
Cap. Flow
-$168B
Cap. Flow %
-27.5%
Top 10 Hldgs %
30.63%
Holding
3,114
New
154
Increased
1,364
Reduced
1,248
Closed
171

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.76B
2
LLY icon
Eli Lilly
LLY
+$1.4B
3
BAC icon
Bank of America
BAC
+$1.3B
4
TSLA icon
Tesla
TSLA
+$1.19B
5
WFC icon
Wells Fargo
WFC
+$784M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$6.47B
2
AMZN icon
Amazon
AMZN
+$3.71B
3
YUM icon
Yum! Brands
YUM
+$2.84B
4
CRM icon
Salesforce
CRM
+$2.77B
5
FTV icon
Fortive
FTV
+$2.41B

Sector Composition

Rank Sector Weight
1 Technology 26.06%
2 Healthcare 18.72%
3 Consumer Discretionary 14.62%
4 Financials 10.36%
5 Communication Services 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DS
2876
DELISTED
Drive Shack Inc.
DS
$32K ﹤0.01%
51,350
+26,000
+103% +$31.1K
EVLV icon
2877
Evolv Technologies
EVLV
$1.03B
$31K ﹤0.01%
+14,166
New +$37K
PRCH icon
2878
Porch Group
PRCH
$1.85B
$31K ﹤0.01%
13,459
-11,349
-46% -$27.5K
SB icon
2879
Safe Bulkers
SB
$781M
$31K ﹤0.01%
+12,226
New +$41.4K
RUBY
2880
DELISTED
Rubius Therapeutics, Inc
RUBY
$31K ﹤0.01%
70,400
AGTC
2881
DELISTED
Applied Genetic Technologies Corporation
AGTC
$30K ﹤0.01%
108,680
-153,375
-59% -$67K
ATOS icon
2882
Atossa Therapeutics
ATOS
$24.1M
$29K ﹤0.01%
2,293
UP icon
2883
Wheels Up
UP
$186M
$29K ﹤0.01%
125
+49
+64% +$19.6K
ADV icon
2884
Advantage Solutions
ADV
$417M
$28K ﹤0.01%
521
-315,150
-100% -$29.1M
CTXR icon
2885
Citius Pharmaceuticals
CTXR
$19.6M
$28K ﹤0.01%
896
NAGE
2886
Niagen Bioscience
NAGE
$241M
$28K ﹤0.01%
22,500
CMRX
2887
DELISTED
Chimerix, Inc.
CMRX
$28K ﹤0.01%
+14,279
New +$32K
BKKT icon
2888
Bakkt Inc
BKKT
$328M
$27K ﹤0.01%
+449
New +$30K
CLSD
2889
DELISTED
Clearside Biomedical
CLSD
$27K ﹤0.01%
1,547
LIDR icon
2890
AEye
LIDR
$60.4M
$27K ﹤0.01%
797
IMDX
2891
Insight Molecular Diagnostics
IMDX
$137M
$27K ﹤0.01%
1,830
HLGN
2892
DELISTED
Heliogen, Inc.
HLGN
$27K ﹤0.01%
+401
New +$31.3K
FATH
2893
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$27K ﹤0.01%
651
HYZN
2894
DELISTED
Hyzon Motors Inc. Class A Common Stock
HYZN
$26K ﹤0.01%
+299
New +$39.3K
VIEW
2895
DELISTED
View, Inc. Class A Common Stock
VIEW
$26K ﹤0.01%
+319
New +$36.2K
GRNA
2896
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
$26K ﹤0.01%
+10,976
New +$28.7K
SKIL icon
2897
Skillsoft
SKIL
$75.9M
$25K ﹤0.01%
+679
New +$46.6K
CELU icon
2898
Celularity
CELU
$20.4M
$24K ﹤0.01%
+1,024
New +$31.1K
APPH
2899
DELISTED
AppHarvest, Inc. Common Stock
APPH
$24K ﹤0.01%
+12,171
New +$39.4K
OUST icon
2900
Ouster
OUST
$3.33B
$23K ﹤0.01%
2,361
+1,118
+90% +$17.2K

Similar funds

T. Rowe Price Associates's Q3 2022 Portfolio in Review

As of Q3 2022, T. Rowe Price Associates held 3,114 positions worth $610B, down 23% from $791B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

T. Rowe Price Associates withdrew a net $168B in Q3 2022, closing 171 positions and reducing 1,248 holdings. Its most notable exit was Alcon, an estimated $1.51B position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, T. Rowe Price Associates opened a new position in Corebridge Financial worth $194M.

  • T. Rowe Price Associates's largest Q3 2022 buy was Corebridge Financial: 9,831,688 shares worth $194M.
  • T. Rowe Price Associates added most to ExxonMobil in Q3 2022, an estimated $1.76B increase.
  • T. Rowe Price Associates's biggest Q3 2022 reduction was Microsoft, cutting an estimated $6.47B.
  • T. Rowe Price Associates fully exited Alcon in Q3 2022, selling an estimated $1.51B.
  • T. Rowe Price Associates's ten largest holdings make up 31% of its $610B portfolio in Q3 2022.
  • T. Rowe Price Associates opened 154 new positions and closed 171 in Q3 2022.
  • T. Rowe Price Associates's portfolio value fell 23% quarter-over-quarter to $610B.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.